MURA(Delisted)
Mural Oncology·NASDAQ
--
--(--)
5.17 / 10
Netural
Analyst ratings show 67% Strong Buy but 50% historical accuracy, with Jones Trading (-9.8% avg return) and HC Wainwright (7.2% avg return) offering conflicting signals. Capital flows show 46%+ inflows across all sizes despite negative price action, creating mixed momentum signals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-03-26
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of MURA?
- MURA holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.17/10 (Netural).
